161 - 170 of 8100 Results
Title
Year
-
OPENTitle: Biomarker Assessment in Parkinson’s Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical MeasuresJournal Name: Journal of Alzheimer's Disease ReportsPublisher: SAGE PublicationsVol: 8Issue #: 1Start Page: 1361End Page: 1371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/adr-240110Citation Count: 0
-
OPENTitle: Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00805-zCitation Count: 0
-
RESTRICTEDTitle: Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 11Start Page: 3702End Page: 3713Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awae303Citation Count: 0
-
OPENTitle: Medication recommendation for Parkinson’s disease based on dynamics of symptom progressionJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-76941-6Citation Count: 0
-
OPENTitle: Oral and gut microbiome profiles in people with early idiopathic Parkinson’s diseaseJournal Name: Communications MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s43856-024-00630-8Citation Count: 0
-
OPENTitle: Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.14249Citation Count: 0
- Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT22024OPENTitle: Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00819-7Citation Count: 0
-
OPENTitle: “Reply: Improving Insight and Application: A Commentary on the Link between Initial Depression and Anxiety and Long‐Term Health Outcomes in Parkinson's Disease Patients”Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.14231Citation Count: 0
-
OPENTitle: The Black and African American Connections to Parkinson’s Disease (BLAAC PD) study protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03914-7Citation Count: 0
-
RESTRICTEDTitle: Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sampleJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 30Issue #: 13Start Page: 1642End Page: 1652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/13524585241282763Citation Count: 1